Dynamic changes in aortic impedance after transcatheter aortic valve replacement and its impact on exploratory outcome

Valvulo-arterial impedance (Zva) has been shown to predict worse outcome in medically managed aortic stenosis (AS) patients. We aimed to investigate the association between Zva and left ventricular (LV) adaptation and to explore the predictive value of Zva for cardiac functional recovery and outcome...

Full description

Saved in:
Bibliographic Details
Published in:The International Journal of Cardiovascular Imaging Vol. 33; no. 11; pp. 1693 - 1701
Main Authors: Kobayashi, Yukari, Kim, Juyong B., Moneghetti, Kegan J., Kobayashi, Yuhei, Zhang, Ran, Brenner, Daniel A., O’Malley, Ryan, Schnittger, Ingela, Fischbein, Michael, Miller, D. Craig, Yeung, Alan C., Liang, David, Haddad, Francois, Fearon, William F.
Format: Journal Article
Language:English
Published: Dordrecht Springer Netherlands 01-11-2017
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Valvulo-arterial impedance (Zva) has been shown to predict worse outcome in medically managed aortic stenosis (AS) patients. We aimed to investigate the association between Zva and left ventricular (LV) adaptation and to explore the predictive value of Zva for cardiac functional recovery and outcome after transcatheter aortic valve replacement (TAVR). We prospectively enrolled 128 patients with AS who underwent TAVR. Zva was calculated as: (systolic blood pressure + mean transaortic gradient)/stroke volume index). Echocardiographic assessment occurred at baseline, 1-month and 1-year after TAVR. The primary endpoints were to investigate associations between Zva and global longitudinal strain (GLS) at baseline as well as GLS change after TAVR. The secondary was to compare all-cause mortality after TAVR between patients with pre-defined Zva (=5 mmHg m 2 /ml), stroke volume index (=35 ml/m 2 ), and GLS (=−15%) cutoffs. The mean GLS was reduced (−13.0 ± 3.2%). The mean Zva was 5.2 ± 1.6 mmHg*m 2 /ml with 55% of values ≥5.0 mmHg*m 2 /ml, considered to be abnormally high. Higher Zva correlated with worse GLS (r = −0.33, p < 0.001). After TAVR, Zva decreased significantly (5.1 ± 1.6 vs. 4.5 ± 1.6 mmHg*m 2 /ml, p = 0.001). A reduction of Zva at 1-month was associated with GLS improvement at 1-month (r = −0.31, p = 0.001) and at 1-year (r = −0.36 and p = 0.001). By Kaplan–Meier analysis, patients with higher Zva at baseline had higher mortality (Log-rank p = 0.046), while stroke volume index and GLS did not differentiate outcome (Log-rank p = 0.09 and 0.25, respectively). As a conclusion, Zva is correlated with GLS in AS as well as GLS improvement after TAVR. Furthermore, a high baseline Zva may have an additional impact to traditional parameters on predicting worse mortality after TAVR.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1569-5794
1573-0743
1875-8312
DOI:10.1007/s10554-017-1155-6